News

Regulatory affairsRegulatory Round-up - January 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Understanding life with Beta ThalassemiaUnderstanding life with Beta ThalassemiaCGT Catapult and Autolomous showcase benefits of digital technologies in advanced therapy manufacturingCGT Catapult and Autolomous showcase benefits of digital technologies in advanced therapy manufacturingRegulatory Round-up - September 2025Regulatory Round-up - September 2025R&D project spotlight: Deciphering rAAV production dynamics in HEK293 clones through multi-omics profilingR&D project spotlight: Deciphering rAAV production dynamics in HEK293 clones through multi-omics profilingCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsThe case for collaboration: Why going it alone is no longer an option in advanced therapy developmentThe case for collaboration: Why going it alone is no longer an option in advanced therapy developmentRegulatory Round-up - August 2025Regulatory Round-up - August 2025R&D project spotlight: Developing a smart bioprocessing platform integrating real-time process monitoring and advanced process control for autologous cell therapyR&D project spotlight: Developing a smart bioprocessing platform integrating real-time process monitoring and advanced process control for autologous cell therapyRegulatory Round-up - July 2025Regulatory Round-up - July 2025MHRA introduces regulations that allow decentralised manufacturing of therapiesMHRA introduces regulations that allow decentralised manufacturing of therapiesCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new ChairCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new ChairCell and Gene Therapy Catapult appoints Dr Ed Samuel as Chief Operating OfficerCell and Gene Therapy Catapult appoints Dr Ed Samuel as Chief Operating Officer